| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 98,913 | 72,020 | 62,849 | 110,344 | | Cost of Revenue | 58,005 | 47,636 | 42,467 | 70,189 | | | Gross Profit | 40,908 | 24,384 | 20,382 | 40,155 | | | Operating Expenses | | Research Development | 13,721 | 13,163 | 12,886 | 15,180 | | Selling General and Administrative | 21,042 | 18,336 | 20,093 | 22,901 | | Non Recurring | (217) | 3,657 | 4,431 | 75,936 | | Others | 1,777 | 1,831 | 1,829 | 3,215 | | | | Total Operating Expenses | 36,323 | 36,987 | 39,239 | 117,232 | | | | Operating Income or Loss | 4,585 | (12,603) | (18,857) | (77,077) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,097) |
-
|
-
| 7,557 | | Earnings Before Interest And Taxes | 3,488 | (12,603) | (18,857) | (69,520) | | Interest Expense | 1,656 | 1,698 | 1,709 | 3,487 | | Income Before Tax | 1,832 | (14,301) | (20,566) | (73,007) | | Income Tax Expense | 562 | 402 | 378 | (968) | | Minority Interest |
-
| 65 |
-
| 30 | | | | Net Income From Continuing Ops | 1,270 | (14,638) | (20,944) | (72,009) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,270 | (14,638) | (20,944) | (72,009) | | Preferred Stock And Other Adjustments |
-
| (42) | 42 |
-
| | | Net Income Applicable To Common Shares | $1,270 | ($14,680) | ($20,902) | ($72,009) |
|
0.22% Nasdaq 
Income Statement
